RxDoctor Payments Data

Adeel Ahmad, MD

Physical Medicine & Rehabilitation · Hazlet, NJNPI 1912108044

Payments from drug & device makers

What this record shows

This record is dominated by education: $1,872 of the $2,578 with a category attached, or 72.6%. Arthrex accounts for 74.0% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $2,240 and has fallen 95.0% since, to $111 in 2025.

$2,578in general payments, 2019–2025

Across 43 payments — averaging $59.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$2K
  • Collegium Pharmaceutical, Inc.$152
  • Biosense Webster, Inc.$124
  • Si-bone, Inc.$92
  • Johnson & Johnson$56
  • SPR Therapeutics, Inc$50
  • plus $196 from 7 others

What the payments were for

  • Food & beverage$70627%
  • Education$1,87273%

General payments by program year

19
20
21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,578 in reported general payments places this provider in the 85th percentile of 434 physical medicine & rehabilitation providers in New Jersey.

See all physical medicine & rehabilitation providers in New Jersey

Medicare billing

Part B allowed, 2024
$297,894
Medicare patients
346
Services billed
10,996

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl22$10,231
NucyntaTapentadol Hcl24$7,726
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen160$2,883
Fentanyl22$2,282
Diclofenac Sodium46$2,270
Gabapentin152$1,717
Pregabalin99$1,270
Lidocaine18$1,176
Oxycodone Hcl82$753
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen79$723
Cyclobenzaprine Hcl93$642
Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine30$635
Ibuprofen30$486
Celecoxib24$459
Tramadol Hcl69$366

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Nucynta$152$7,72624 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 434 physical medicine & rehabilitation providers in New Jersey.

Other physical medicine & rehabilitation in Hazlet

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →